The antimicrobial susceptibility testing market is driven by rising antimicrobial resistance, increased demand for precise diagnostics, and advancements in testing technologies.
The Antimicrobial Susceptibility Testing (AST) market has become a cornerstone in modern healthcare, playing a pivotal role in combating the growing threat of antimicrobial resistance (AMR). With the rise of multidrug-resistant pathogens, the need for accurate, efficient, and rapid AST solutions is more urgent than ever. This blog explores the key drivers, challenges, and advancements shaping the AST market, along with its future trajectory.
ููู ุฌุจุณ ุจูุฑุฏ ุงููููุช
ะะฝะปะฐะนะฝ ะผะฐะณะฐะทะธะฝ, ะฒ ะบะพัะพัะพะผ ะผะพะถะฝะพ ะฟัะธะพะฑัะตััะธ ะดะธะฟะปะพะผ ัะฝะธะฒะตััะธัะตัะฐ
ะะตัะฐะปัะฝะพะต ะพะฟะธัะฐะฝะธะต ะฟะพะบัะฟะบะธ ะดะธะฟะปะพะผะฐ ะฒ ะทะฝะฐะผะตะฝะธัะพะผ ะผะฐะณะฐะทะธะฝะต
รskรผdar su kaรงaฤฤฑ tespiti
ะงัะพ ะณะพัะพะฒ ะฒ ะฝะฐัะต ะฒัะตะผั ะฟัะตะดะปะพะถะธัั ะธะฝัะตัะฝะตั ะผะฐะณะฐะทะธะฝ ั ะดะธะฟะปะพะผะฐะผะธ?
